Isovue-370 and Electrocardiogram st segment elevation - a phase IV clinical study of FDA data

Summary:

Electrocardiogram st segment elevation is reported as a side effect among people who take Isovue-370 (iopamidol), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Coreg, and have Troponin increased.

The phase IV clinical study analyzes which people have Electrocardiogram st segment elevation when taking Isovue-370. It is created by eHealthMe based on reports of 505 people who have side effects when taking Isovue-370 from the FDA, and is updated regularly.

What is Isovue-370?

Isovue-370 has active ingredients of iopamidol. eHealthMe is studying from 506 Isovue-370 users. Check the latest studies of Isovue-370.

What is Electrocardiogram st segment elevation?

Electrocardiogram st segment elevation is found to be associated with 397 drugs and 812 conditions by eHealthMe. Check the latest studies of Electrocardiogram st segment elevation.

On Jul, 08, 2026

505 people reported to have side effects when taking Isovue-370.
Among them, 12 people (2.38%) have Electrocardiogram st segment elevation.

Could Isovue-370 cause Electrocardiogram st segment elevation?

Among these 12 people:

How long have people been on Isovue-370 when they have Electrocardiogram st segment elevation? *

What is the gender of people who have Electrocardiogram st segment elevation when taking Isovue-370? *

female: 50 %
male: 50 %

What is the age of people who have Electrocardiogram st segment elevation when taking Isovue-370? *

What are other drugs people take besides Isovue-370? *

What are other side effects people have besides Electrocardiogram st segment elevation? *

Hypotension (abnormally low blood pressure): 8 people, 66.67%
Chest Pain: 7 people, 58.33%
Procedural Complication: 2 people, 16.67%
Heart Rate Decreased: 2 people, 16.67%
Bradycardia (abnormally slow heart action): 2 people, 16.67%
Procedural Hypotension: 1 person, 8.33%
Heart Rate Irregular: 1 person, 8.33%
Coronary Artery Stenosis (narrowing of coronary artery): 1 person, 8.33%
Cardiac Arrest: 1 person, 8.33%

What are the existing conditions these people have? *

Troponin Increased: 2 people, 16.67%
Percutaneous Coronary Intervention: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Isovue-370 and have Electrocardiogram st segment elevation?

- Check whether Electrocardiogram st segment elevation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Isovue-370:

Isovue-370 (506 reports)

Electrocardiogram st segment elevation treatments and more:

Electrocardiogram st segment elevation (4,750 reports)

How severe was Electrocardiogram st segment elevation and when was it recovered:

Electrocardiogram st segment elevation in Isovue-370

Expand to all the drugs that have ingredients of iopamidol:

Electrocardiogram st segment elevation and drugs with ingredients of iopamidol (45 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Isovue-370:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Electrocardiogram st segment elevation:

Electrocardiogram st segment elevation (397 drugs)

Browse all the conditions that are associated with Electrocardiogram st segment elevation:

Electrocardiogram st segment elevation (812 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on iopamidol (the active ingredients of Isovue-370) and Isovue-370 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.